News Stories

TTVR Remains Safe, Effective in Presence of CIED Leads

The rate of death or HF hospitalization was not influenced by the presence of leads after accounting for comorbidity burden.

FDA details Class I recalls for more than 1 million pacemakers—software update required

A variety of Boston Scientific devices are included in these recalls. This includes the Accolade, Proponent, Essentio and Altura 2 dual chamber standard life and extended life pacemakers in addition to the Visionist and Valitude CRT pacemakers.

FDA approves Zoll’s newest defibrillator-monitor

The device includes new features based on years of user feedback.

CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF

The Integra-D trial shows the device, which provides cardiac contractility modulation and defibrillation, also eases symptoms

Prophylactic Pacemakers After TAVI Provide Little Benefit: PROMOTE

Implanting pacemakers in those who meet criteria for prophylactic use appears to be overtreating some patients.